Brief: Xbrane Biopharma Q2 EBITDA SEK -6.3 Million
17/07/2026 07:31
BRIEF-Xbrane Biopharma Q2 EBITDA SEK -6.3 Million Jul 17 (Reuters) - Xbrane Biopharma Q2 EPS SEK -0.55.
- Q2 revenue SEK 46.8 million
- Q2 net income SEK -11.4 million
XBRANE — Xbrane Biopharma AB News Story
0.000.00%
Last trade - 00:00- SEK235.93m
- SEK262.45m
- SEK152.35m